Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Amgen Biotech Experience
AddedFeb 17, 2024
UpdatedJun 18, 2026
Amgen Biotech Experience

Amgen Biotech Experience

Amgen Biotech Experience: A hands-on science education program for secondary schools, inspiring future biotech innovators.

HQ
Waltham, MA, US
Founded
2016
Overview
Compare
Fundraising
Employees
Website

The Amgen Biotech Experience (ABE) was founded with the mission to inspire the next generation of biotech innovators through hands-on science education. The program offers professional development for teachers, along with research-grade equipment, teaching materials, and a comprehensive molecular biology curriculum to secondary schools. ABE aims to bring the excitement of scientific discovery to classrooms, focusing on biotechnology education. It operates globally, reaching over 90,000 students and 1,500 teachers annually across 16 countries.

Notable affiliated individuals include educators and scientists who contribute to the program's curriculum and training. The initiative is supported by Amgen, a leading biotechnology company, which provides significant funding and resources. Key achievements include the widespread adoption of its curriculum and the positive impact on students' interest in science careers. Overall, ABE has made a substantial impact by enhancing science education and fostering a deeper understanding of biotechnology among young students worldwide.

Amgen Biotech Experience - Similar Companies

Applied Biotech logo

Applied Biotech

appliedbiotech.net

Digital World Biology logo

Digital World Biology

Accelerator Life Science Partners logo

Accelerator Life Science Partners

acceleratorlsp.com

Stemkids logo

Stemkids

Edvotek logo

Edvotek

Biotech Holdings logo

Biotech Holdings

Amber Bio logo

Amber Bio

amber.bio

ABio-X logo

ABio-X

abio-x.com

Ampersand Biomedicines logo

Ampersand Biomedicines

ampersand.bio

Science Bits logo

Science Bits

Stem Innovator logo

Stem Innovator

Arcadia Science logo

Arcadia Science

arcadiascience.com

Innovative Genetics logo

Innovative Genetics

Insightful Science logo

Insightful Science

Carmolex logo

Carmolex

Amgen Biotech Experience - Quick Facts

Who are Amgen Biotech Experience's competitors?

Companies similar to Amgen Biotech Experience include Applied Biotech, Digital World Biology, Accelerator Life Science Partners and Stemkids.

When was Amgen Biotech Experience founded?

Amgen Biotech Experience was founded in 2016.

Where is Amgen Biotech Experience's headquarters located?

Amgen Biotech Experience's headquarters is located in Waltham, MA, US.

When was Amgen Biotech Experience's last funding round?

Amgen Biotech Experience's most recent funding round was for $2.5M (USD) in November 2013.

How much has Amgen Biotech Experience raised to-date?

As of Nov 11, 2013, Amgen Biotech Experience has raised a total of $2.5M (USD).

How many employees does Amgen Biotech Experience have?

Amgen Biotech Experience has 62 employees as of Feb 4, 2024.

Amgen Biotech Experience - Classification

Technology
  • Biotech
Geographic Exposure
  • Global
Customer
  • Education
  • Non-Profit
Main Product
  • Science Education
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
Show 5 more industry codes
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 7372Prepackaged Software